Alzheon
Likely to Engage tag.Highly Engaged Employees

Manufacturing · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

111 Speen St Ste 306, Framingham, Massac...

Phone Number

(508) 861-7709

Revenue

$6.3 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Alzheon

Alzheon is a clinical-stage biopharmaceutical company focused on developing innovative medicines for patients with Alzheimer's disease and other neurological disorders. The company is advancing its lead program, Valiltramiprosate (ALZ-801), which is currently in Phase 3 trials and aims to inhibit amyloid aggregation. Alzheon employs a precision medicine approach and has a discovery platform for small molecules targeting neurodegenerative conditions. Their intended clients include patients suffering from Alzheimer's disease, particularly those with specific genetic profiles.Explore more
Alzheon's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Alzheon Org Chart

PhoneEmail
YK
United States flag for contact location.

Chief of Staff

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
SK
United States flag for contact location.

Head of Quality Vice President, Quality

PhoneEmail
EL
United States flag for contact location.

Vice President, Clinical Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Alzheon

Compare insights from companies similar to Alzheon, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Alzheon

$6.3M
11-50
Private
$260.8M
2013
YK
Yasemin KhakianChief of Staff
$16.4M
11-50
Private
$99.8M
2012
N/A
$5.3M
11-50
Private
$36.9M
2010
Jerry St. Peter, Chief Executive Officer & Director, Board at PolyActiva
Jerry St. PeterCEO & Director, Board
<$5M
1-10
Private
$52M
2007
David Block, Gliknik Co-Founder and Chief Executive Officer at Gliknik
David BlockGliknik Co-Founder and CEO
<$5M
11-50
Public
$37.6M
2015
<$5M
51-200
Public
$140.3M
2013
MB
Morgan BrownChief Financial Officer
Illustration of an envelope

Alzheon Tech Stack

A closer look at the technologies used by Alzheon

Top Manufacturing Companies

Frequently Asked Questions Regarding Alzheon

What is Alzheon's official website?
Alzheon's official website is www.alzheon.com
What is Alzheon's Revenue?
Alzheon's revenue is $6.3 Million
What is Alzheon's SIC code?
Alzheon's SIC: 28,283
What is Alzheon's NAICS code?
Alzheon's NAICS: 32,325
How many employees does Alzheon have?
Alzheon has 11-50 employees
What industry does Alzheon belong to?
Alzheon is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Alzheon competition?
Alzheon top competitors include: Clene Nanomedicine, PellePharm, Gliknik, Daré Bioscience
What technology does Alzheon use?
Some of the popular technologies that Alzheon uses are: WordPress.org, PHP, Google Cloud Web Serving, Google Cloud Platform
How do I contact Alzheon?
Alzheon contact info: Phone number: (508) 861-7709 Website: www.alzheon.com
What does Alzheon do?

Alzheon is a clinical-stage biopharmaceutical company focused on developing innovative medicines for patients with Alzheimer's disease and other neurological disorders. The company is advancing its lead program, Valiltramiprosate (ALZ-801), which is currently in Phase 3 trials and aims to inhibit amyloid aggregation. Alzheon employs a precision med... icine approach and has a discovery platform for small molecules targeting neurodegenerative conditions. Their intended clients include patients suffering from Alzheimer's disease, particularly those with specific genetic profiles.Read More

What are Alzheon social media links?
Alzheon Linkedin page Alzheon Twitter page
Who invested in Alzheon?
Alzheon has 10 investors including Alerce Medical Technology Partners and PPP.
Is Alzheon a public company?
Alzheon is private company therefore does not currently have an official ticker symbol
See more information about Alzheon

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.